Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon
Clin Mol Hepatol. 2021;27(1):157-174.   Published online 2020 Nov 26     DOI: https://doi.org/10.3350/cmh.2020.0176
Citations to this article as recorded by Crossref logo
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
Friedrich Foerster, Simon Johannes Gairing, Lukas Müller, Peter Robert Galle
Journal of Hepatology.2022; 76(2): 446.     CrossRef
Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
International Journal of Cancer.2022; 150(10): 1587.     CrossRef
Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models
Ofir Ben-Assuli, Arie Jacobi, Orit Goldman, Shani Shenhar-Tsarfaty, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo Berliner, Shira Zelber-Sagi
Journal of Biomedical Informatics.2022; 126: 103986.     CrossRef
Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer
Lei Wang, Liping Liang, Shuzhen Shi, Chao Wang, Fahd Abd Algalil
Applied Bionics and Biomechanics.2022; 2022: 1.     CrossRef
Insulin and cancer: a tangled web
Brooks P. Leitner, Stephan Siebel, Ngozi D. Akingbesote, Xinyi Zhang, Rachel J. Perry
Biochemical Journal.2022; 479(5): 583.     CrossRef
Effects of image-guided adaptive radiotherapy combined with hepatic artery chemoembolization in primary liver cancer patients
Yingchun Zhao, Changwang Zhang, Yongqian Zhang, Changwen Bo, Yonghui An, Na Li, Wenhua Ma, Changpeng Zou, Liping Zhao, Sujing Zhang
Clinics and Research in Hepatology and Gastroenterology.2022; 46(5): 101889.     CrossRef
Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
Zijun Yan, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao, Tong Chen, Fu Wang
Journal of Immunology Research.2022; 2022: 1.     CrossRef
Risk factors of liver malignancies in workers chronically exposed to ionizing radiation
Galina V. Zhuntova, Mariya V. Bannikova, Tamara V. Azizova
Ekologiya cheloveka (Human Ecology).2022; 29(5): 333.     CrossRef
Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information
Chuanmei Zhu, Hongbo Ma, Anqi He, Yi Li, Chengqi He, Yong Xia
Cancer Letters.2022; 544: 215814.     CrossRef
Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Pil Soo Sung
Clinical and Molecular Hepatology.2022; 28(3): 333.     CrossRef
The timing of adiposity and changes in the life course on the risk of cancer
Zhe Fang, Edward L. Giovannucci
Cancer and Metastasis Reviews.2022; 41(3): 471.     CrossRef
Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi
BMC Cancer.2022;[Epub]     CrossRef
Response to Liao et al.
Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(10): 1718.     CrossRef
Current cancer burden in China: epidemiology, etiology, and prevention
Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng, Wanqing Chen
Cancer Biology & Medicine.2022; 19(8): 1121.     CrossRef
Metabolic syndrome, obesity and cancer risk
Federico Belladelli, Francesco Montorsi, Alberto Martini
Current Opinion in Urology.2022; 32(6): 594.     CrossRef
Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
Cancers.2022; 14(20): 5002.     CrossRef
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clinical and Molecular Hepatology.2021; 27(1): 87.     CrossRef
Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma
De-Chen Yu, Xiang-Yi Chen, Xin Li, Hai-Yu Zhou, De-Quan Yu, Xiao-Lei Yu, Yi-Cun Hu, Rui-Hao Zhang, Xiao-Bo Zhang, Kun Zhang, Jiang-Dong An
Scientific Reports.2021;[Epub]     CrossRef
Obesity as a risk factor for diseases of the digestive system
Dmitry N. Andreev, Yury A. Kucheryavyy
Terapevticheskii arkhiv.2021; 93(8): 954.     CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Shira Zelber-Sagi, Mazen Noureddin, Oren Shibolet
Cancers.2021; 14(1): 103.     CrossRef